JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.21B |
| 2 |
Microsoft
MSFT
|
+$2.18B |
| 3 |
Tesla
TSLA
|
+$1.1B |
| 4 |
NXP Semiconductors
NXPI
|
+$1.04B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$998M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$4.32B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.5B |
| 4 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.31B |
| 5 |
PayPal
PYPL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.77% |
| 2 | Financials | 10.48% |
| 3 | Healthcare | 9.83% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
CALL
M&T Bank
MTB
$36.7B
| $2.26M | ﹤0.01% |
+14,700
| New | +$2.26M |
|
3627
iShares Core Universal USD Bond ETF
IUSB
$43.2B
| $2.25M | ﹤0.01% |
42,578
+31,845
| +297% | +$1.69M |
|
3628
Hyatt Hotels
H
$17.1B
| $2.25M | ﹤0.01% |
23,486
+1,120
| +5% | +$95.6K |
|
|
CMBM
3629
DELISTED
Cambium Networks
CMBM
| $2.25M | ﹤0.01% |
87,765
-6,612
| -7% | -$191K |
|
3630
LSI Industries
LYTS
$913M
| $2.25M | ﹤0.01% |
327,642
-36,577
| -10% | -$276K |
|
3631
Entravision Communication
EVC
$832M
| $2.24M | ﹤0.01% |
330,423
+183,662
| +125% | +$1.39M |
|
3632
XPEL
XPEL
$1.38B
| $2.24M | ﹤0.01% |
32,748
+12,191
| +59% | +$879K |
|
3633
Century Therapeutics
IPSC
$348M
| $2.23M | ﹤0.01% |
140,953
+77,529
| +122% | +$1.46M |
|
|
SJIV
3634
DELISTED
South Jersey Industries, Inc. Corporate Units
SJIV
| $2.23M | ﹤0.01% |
40,000
| – | – |
|
3635
Lands' End
LE
$384M
| $2.23M | ﹤0.01% |
113,546
+11,080
| +11% | +$257K |
|
|
ATHX
3636
DELISTED
Athersys, Inc. Common Stock
ATHX
| $2.23M | ﹤0.01% |
98,775
-22,535
| -19% | -$646K |
|
3637
SmartFinancial
SMBK
$902M
| $2.23M | ﹤0.01% |
81,402
+6,304
| +8% | +$167K |
|
3638
PUT
NetApp
NTAP
$40.6B
| $2.23M | ﹤0.01% |
24,200
| – | – |
|
3639
State Street Nuveen Municipal Bond ETF
MBND
$26.9M
| $2.22M | ﹤0.01% |
74,695
-200,000
| -73% | -$5.97M |
|
3640
MarineMax
HZO
$1.15B
| $2.22M | ﹤0.01% |
37,531
+370
| +1% | +$19.8K |
|
3641
PUT
International Flavors & Fragrances
IFF
$21.5B
| $2.21M | ﹤0.01% |
+14,700
| New | +$2.14M |
|
|
KRTX
3642
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $2.21M | ﹤0.01% |
16,901
+1,388
| +9% | +$179K |
|
|
INZY
3643
DELISTED
Inozyme Pharma
INZY
| $2.21M | ﹤0.01% |
324,387
-7,504
| -2% | -$64.8K |
|
|
JNCE
3644
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $2.2M | ﹤0.01% |
263,893
-28,532
| -10% | -$235K |
|
3645
CALL
Suburban Propane Partners
SPH
$1.18B
| $2.2M | ﹤0.01% |
+150,000
| New | +$2.27M |
|
3646
Smith & Wesson
SWBI
$643M
| $2.19M | ﹤0.01% |
123,146
+39,857
| +48% | +$823K |
|
3647
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
| $2.19M | ﹤0.01% |
25,009
-53,395
| -68% | -$4.74M |
|
3648
Nuveen Multi-Asset Income Fund
NMAI
$494M
| $2.19M | ﹤0.01% |
+117,352
| New | +$2.13M |
|
3649
Tucows
TCX
$126M
| $2.19M | ﹤0.01% |
26,077
+6,589
| +34% | +$551K |
|
3650
TriMas Corp
TRS
$1.4B
| $2.18M | ﹤0.01% |
59,023
+1,604
| +3% | +$55.3K |
|
Similar funds
JP Morgan Chase's Q4 2021 Portfolio in Review
As of Q4 2021, JP Morgan Chase held 7,322 positions worth $866B, up 7.1% from $809B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2021 filing shows 665 new, 2,967 increased, 2,175 reduced and 543 closed positions. Its largest new stake was Rivian: 4,642,731 shares worth $481M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $4.32B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2021 buy was Rivian: 4,642,731 shares worth $481M.
- JP Morgan Chase added most to Amazon in Q4 2021, an estimated $2.21B increase.
- JP Morgan Chase's biggest Q4 2021 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $4.32B.
- JP Morgan Chase fully exited Kansas City Southern in Q4 2021, selling an estimated $499M.
- JP Morgan Chase's ten largest holdings make up 17% of its $866B portfolio in Q4 2021.
- JP Morgan Chase opened 665 new positions and closed 543 in Q4 2021.
- JP Morgan Chase's portfolio value rose 7.1% quarter-over-quarter to $866B.
Based on JP Morgan Chase's 13F filing for Q4 2021, filed 10 Feb 2022.